[{"Assets_0_Q3_USD":122929000.0,"CommonStockSharesOutstanding_0_Q3_shares":163204000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-9485000.0,"NetIncomeLoss_1_Q3_USD":1043000.0,"NetIncomeLoss_3_Q3_USD":-6722000.0,"StockholdersEquity_0_Q3_USD":44415000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":163119000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":162109000.0,"Ticker":"ATRS","CIK":"1016169","name":"ANTARES PHARMA, INC.","OfficialName":"Antares Pharma Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"948492298.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NASDAQ","SP500":"nan","filed":"20191105"}]